

Cover Story
By Claire Dietz and Paul Goldberg
“If you want to see what a cure looks like, you already have,” said Tom Whitehead as his daughter Emily joined him at the lectern at the public hearing of the FDA Oncologic Drugs Advisory Committee July 12.“She's standing right beside me.”
In Brief
Drugs & Targets
Trending Stories
- NCI releases names of members of ad hoc working group—filling the void left by BSA
- Jonathan Mahler on his front-page story in the NYT Magazine on Trump’s deliberate dismantling of America’s War on Cancer
- ACOG says it will no longer accept federal funding
- NCI is “really, really sturdy” and won’t break, former directors Ned Sharpless and Kim Rathmell say at UNC Lineberger symposium
- Gonzalez-Angulo Found Guilty In MD Anderson Poisoning Case
- AACR Cancer Progress Report makes the case for federal investment in cancer research